Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schistosoma mansoni | 30 | 2026 | 31 | 3.770 |
Why?
|
| Thioredoxin-Disulfide Reductase | 10 | 2026 | 10 | 1.790 |
Why?
|
| Enzyme Inhibitors | 10 | 2026 | 75 | 1.440 |
Why?
|
| NADH, NADPH Oxidoreductases | 13 | 2026 | 13 | 1.230 |
Why?
|
| Multienzyme Complexes | 13 | 2026 | 20 | 1.230 |
Why?
|
| Animals | 45 | 2026 | 2092 | 1.200 |
Why?
|
| Cryptosporidium parvum | 2 | 2026 | 2 | 1.130 |
Why?
|
| Cryptosporidium | 1 | 2025 | 1 | 0.890 |
Why?
|
| Protozoan Proteins | 1 | 2025 | 1 | 0.890 |
Why?
|
| Antimalarials | 5 | 2026 | 9 | 0.850 |
Why?
|
| Oxidation-Reduction | 11 | 2026 | 33 | 0.830 |
Why?
|
| Gene Expression Profiling | 5 | 2013 | 63 | 0.820 |
Why?
|
| Schistosomiasis mansoni | 10 | 2022 | 11 | 0.780 |
Why?
|
| Aminoacyltransferases | 2 | 2013 | 2 | 0.740 |
Why?
|
| Ancylostoma | 3 | 2019 | 3 | 0.640 |
Why?
|
| Auranofin | 6 | 2025 | 6 | 0.640 |
Why?
|
| Peroxiredoxins | 8 | 2021 | 9 | 0.610 |
Why?
|
| Naphthoquinones | 4 | 2024 | 4 | 0.610 |
Why?
|
| Schistosomicides | 5 | 2026 | 5 | 0.590 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 99 | 0.570 |
Why?
|
| Anthelmintics | 5 | 2020 | 7 | 0.560 |
Why?
|
| NADP | 5 | 2024 | 9 | 0.540 |
Why?
|
| Mice | 13 | 2026 | 760 | 0.500 |
Why?
|
| Gold | 3 | 2026 | 3 | 0.490 |
Why?
|
| Models, Molecular | 7 | 2026 | 44 | 0.460 |
Why?
|
| Schistosomiasis | 3 | 2023 | 4 | 0.460 |
Why?
|
| Thioredoxin Reductase 1 | 2 | 2025 | 2 | 0.450 |
Why?
|
| Glutathione | 6 | 2025 | 18 | 0.450 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2025 | 13 | 0.440 |
Why?
|
| Hypertension, Pulmonary | 2 | 2026 | 13 | 0.440 |
Why?
|
| Plasmodium falciparum | 4 | 2026 | 4 | 0.430 |
Why?
|
| Crystallography, X-Ray | 7 | 2026 | 12 | 0.420 |
Why?
|
| Peroxidases | 2 | 2006 | 3 | 0.400 |
Why?
|
| Coordination Complexes | 2 | 2026 | 3 | 0.400 |
Why?
|
| Phytochelatins | 1 | 2013 | 1 | 0.400 |
Why?
|
| Molecular Sequence Data | 13 | 2013 | 100 | 0.380 |
Why?
|
| Humans | 24 | 2026 | 12240 | 0.360 |
Why?
|
| Thioredoxins | 4 | 2025 | 5 | 0.340 |
Why?
|
| Gene Expression | 2 | 2011 | 97 | 0.330 |
Why?
|
| Oxidative Stress | 4 | 2025 | 53 | 0.320 |
Why?
|
| Glutathione Reductase | 4 | 2023 | 4 | 0.310 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2019 | 18 | 0.260 |
Why?
|
| Life Cycle Stages | 1 | 2007 | 2 | 0.260 |
Why?
|
| Amino Acid Sequence | 10 | 2013 | 80 | 0.250 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2026 | 2 | 0.240 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2026 | 3 | 0.240 |
Why?
|
| Xanthones | 1 | 2026 | 1 | 0.240 |
Why?
|
| Organogold Compounds | 1 | 2026 | 1 | 0.240 |
Why?
|
| Albumins | 1 | 2006 | 4 | 0.240 |
Why?
|
| DNA, Helminth | 5 | 2013 | 5 | 0.240 |
Why?
|
| Mefloquine | 1 | 2026 | 1 | 0.240 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2025 | 1 | 0.230 |
Why?
|
| Inflammation | 1 | 2026 | 124 | 0.220 |
Why?
|
| Antiparasitic Agents | 2 | 2024 | 2 | 0.220 |
Why?
|
| Cryptosporidiosis | 1 | 2025 | 1 | 0.220 |
Why?
|
| Female | 11 | 2026 | 6974 | 0.220 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 125 | 0.220 |
Why?
|
| Prodrugs | 1 | 2024 | 1 | 0.220 |
Why?
|
| Antigens, Helminth | 2 | 2003 | 2 | 0.210 |
Why?
|
| Malaria, Falciparum | 2 | 2013 | 2 | 0.210 |
Why?
|
| Helminth Proteins | 3 | 2009 | 4 | 0.210 |
Why?
|
| Brugia malayi | 2 | 2022 | 2 | 0.210 |
Why?
|
| Onchocerca volvulus | 2 | 2022 | 2 | 0.210 |
Why?
|
| Structure-Activity Relationship | 6 | 2026 | 27 | 0.200 |
Why?
|
| Flavin-Adenine Dinucleotide | 1 | 2023 | 1 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 5 | 2013 | 33 | 0.190 |
Why?
|
| Drug Design | 1 | 2013 | 9 | 0.190 |
Why?
|
| Cysteine | 4 | 2022 | 7 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2012 | 18 | 0.190 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 74 | 0.180 |
Why?
|
| Oxadiazoles | 2 | 2014 | 3 | 0.180 |
Why?
|
| Parasites | 1 | 2022 | 1 | 0.180 |
Why?
|
| Plants, Medicinal | 1 | 2022 | 3 | 0.180 |
Why?
|
| B-Lymphocytes | 2 | 2003 | 25 | 0.180 |
Why?
|
| Glutathione Peroxidase | 3 | 2006 | 5 | 0.180 |
Why?
|
| Biological Products | 1 | 2022 | 16 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 128 | 0.170 |
Why?
|
| Egg Proteins | 1 | 2001 | 1 | 0.170 |
Why?
|
| Nanostructures | 1 | 2021 | 8 | 0.170 |
Why?
|
| Helminthiasis | 1 | 2020 | 1 | 0.160 |
Why?
|
| Protozoan Infections | 1 | 2020 | 1 | 0.160 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 39 | 0.160 |
Why?
|
| Antiprotozoal Agents | 1 | 2020 | 7 | 0.160 |
Why?
|
| Proteins | 1 | 2021 | 33 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 28 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 61 | 0.160 |
Why?
|
| Disulfides | 2 | 2023 | 3 | 0.150 |
Why?
|
| Molecular Structure | 4 | 2024 | 9 | 0.150 |
Why?
|
| Neoplasms | 1 | 2020 | 94 | 0.150 |
Why?
|
| Oviposition | 1 | 2019 | 2 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 2 | 0.150 |
Why?
|
| Male | 7 | 2026 | 6815 | 0.150 |
Why?
|
| Biomphalaria | 2 | 2009 | 2 | 0.140 |
Why?
|
| Phylogeny | 4 | 2012 | 35 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2013 | 39 | 0.130 |
Why?
|
| Nitric Oxide Donors | 2 | 2014 | 6 | 0.130 |
Why?
|
| Cloning, Molecular | 5 | 2011 | 17 | 0.130 |
Why?
|
| Computational Biology | 3 | 2012 | 11 | 0.130 |
Why?
|
| Nitric Oxide | 3 | 2014 | 36 | 0.130 |
Why?
|
| Hydrogen Peroxide | 3 | 2008 | 21 | 0.120 |
Why?
|
| Base Sequence | 6 | 2006 | 57 | 0.120 |
Why?
|
| Apoptosis | 2 | 2026 | 105 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 13 | 0.110 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 1 | 2015 | 1 | 0.110 |
Why?
|
| Erythrocytes | 1 | 2015 | 13 | 0.110 |
Why?
|
| Loiasis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Onchocerciasis | 1 | 2015 | 1 | 0.110 |
Why?
|
| Microfilariae | 1 | 2015 | 2 | 0.110 |
Why?
|
| Elephantiasis, Filarial | 1 | 2015 | 2 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2025 | 90 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2026 | 37 | 0.110 |
Why?
|
| Praziquantel | 1 | 2014 | 2 | 0.110 |
Why?
|
| Lung | 2 | 2026 | 76 | 0.110 |
Why?
|
| Pyrazines | 1 | 2014 | 7 | 0.110 |
Why?
|
| Isoquinolines | 1 | 2014 | 10 | 0.110 |
Why?
|
| Expressed Sequence Tags | 2 | 2007 | 2 | 0.110 |
Why?
|
| DNA, Complementary | 2 | 2007 | 16 | 0.110 |
Why?
|
| Gene Library | 2 | 2007 | 3 | 0.100 |
Why?
|
| S-Nitrosothiols | 1 | 2014 | 1 | 0.100 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 1 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 39 | 0.100 |
Why?
|
| Ancylostomiasis | 1 | 2013 | 1 | 0.100 |
Why?
|
| Quinoxalines | 1 | 2013 | 4 | 0.100 |
Why?
|
| Genome, Helminth | 2 | 2012 | 2 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 53 | 0.100 |
Why?
|
| Zygote | 1 | 2012 | 1 | 0.090 |
Why?
|
| Quinolines | 1 | 2012 | 5 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 4 | 0.090 |
Why?
|
| Models, Chemical | 1 | 2012 | 31 | 0.090 |
Why?
|
| Cluster Analysis | 2 | 2012 | 23 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2011 | 2 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 8 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 7 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 9 | 0.090 |
Why?
|
| Drug Resistance | 1 | 2011 | 20 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2011 | 157 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 150 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2008 | 90 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2026 | 170 | 0.070 |
Why?
|
| DNA | 4 | 2009 | 57 | 0.070 |
Why?
|
| Antirheumatic Agents | 1 | 2009 | 40 | 0.070 |
Why?
|
| Fasciola hepatica | 1 | 2008 | 1 | 0.070 |
Why?
|
| Fascioliasis | 1 | 2008 | 1 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2008 | 3 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 9 | 0.070 |
Why?
|
| Macrophages | 1 | 2008 | 38 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 54 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2026 | 338 | 0.070 |
Why?
|
| Catalysis | 2 | 2013 | 9 | 0.070 |
Why?
|
| Disease Vectors | 1 | 2007 | 1 | 0.060 |
Why?
|
| RNA, Helminth | 1 | 2007 | 1 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2007 | 2 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 4 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 68 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 229 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 3 | 0.060 |
Why?
|
| Palladium | 1 | 2026 | 1 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 47 | 0.060 |
Why?
|
| Antioxidants | 1 | 2006 | 34 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 60 | 0.060 |
Why?
|
| Cycloaddition Reaction | 1 | 2024 | 1 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2024 | 3 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2024 | 14 | 0.050 |
Why?
|
| Drug Discovery | 2 | 2018 | 6 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 1 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 18 | 0.050 |
Why?
|
| Retroelements | 1 | 2003 | 1 | 0.050 |
Why?
|
| Genome | 1 | 2003 | 4 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosoma haematobium | 1 | 2003 | 1 | 0.050 |
Why?
|
| Schistosomiasis haematobia | 1 | 2003 | 1 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2003 | 4 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 38 | 0.050 |
Why?
|
| Selenoproteins | 1 | 2022 | 1 | 0.050 |
Why?
|
| Kenya | 1 | 2022 | 2 | 0.050 |
Why?
|
| Herbal Medicine | 1 | 2022 | 4 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 11 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 55 | 0.040 |
Why?
|
| Genes, Helminth | 2 | 2009 | 2 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 179 | 0.040 |
Why?
|
| Solubility | 2 | 2012 | 10 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2001 | 10 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2001 | 9 | 0.040 |
Why?
|
| Biopolymers | 1 | 2021 | 3 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2009 | 8 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2020 | 10 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2000 | 4 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 62 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 171 | 0.040 |
Why?
|
| Chromosomes, Bacterial | 1 | 2000 | 2 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 205 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2019 | 15 | 0.040 |
Why?
|
| Kinetics | 2 | 2009 | 110 | 0.040 |
Why?
|
| Electrochemistry | 1 | 2015 | 29 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 117 | 0.030 |
Why?
|
| Chitinases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Hexosaminidases | 1 | 1995 | 1 | 0.030 |
Why?
|
| Streptomyces | 1 | 1995 | 1 | 0.030 |
Why?
|
| Acetylglucosaminidase | 1 | 1995 | 2 | 0.030 |
Why?
|
| Benzyl Compounds | 1 | 2015 | 1 | 0.030 |
Why?
|
| Vitamin K 3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Malaria | 1 | 2015 | 2 | 0.030 |
Why?
|
| Diethylcarbamazine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Filaricides | 1 | 2015 | 1 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2015 | 1 | 0.030 |
Why?
|
| Ivermectin | 1 | 2015 | 1 | 0.030 |
Why?
|
| Loa | 1 | 2015 | 1 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 1 | 0.030 |
Why?
|
| Albendazole | 1 | 2015 | 2 | 0.030 |
Why?
|
| Haplorhini | 1 | 2015 | 6 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1994 | 4 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1994 | 28 | 0.030 |
Why?
|
| Genetic Variation | 1 | 1994 | 44 | 0.030 |
Why?
|
| Nitrosation | 1 | 2014 | 1 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 16 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2013 | 6 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 7 | 0.020 |
Why?
|
| Hemin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Methemoglobin | 1 | 2012 | 1 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 164 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 15 | 0.020 |
Why?
|
| Peroxidase | 1 | 2012 | 6 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 8 | 0.020 |
Why?
|
| Selenocysteine | 1 | 2011 | 1 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 16 | 0.020 |
Why?
|
| Schistosoma | 1 | 2009 | 1 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 8 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 10 | 0.020 |
Why?
|
| Selenium | 1 | 2009 | 2 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 29 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2009 | 1 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2009 | 1 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2009 | 6 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 12 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 9 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 5 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 407 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 4 | 0.020 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2008 | 1 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2008 | 7 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 275 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 3557 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 246 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 1994 | 57 | 0.010 |
Why?
|
| Genomic Library | 1 | 2003 | 1 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2003 | 3 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 27 | 0.010 |
Why?
|
| Parasite Egg Count | 1 | 2003 | 1 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 11 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 29 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2003 | 54 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 2000 | 1 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2000 | 3 | 0.010 |
Why?
|
| DNA Probes | 1 | 2000 | 3 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2000 | 4 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2000 | 12 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 13 | 0.010 |
Why?
|
| Adolescent | 1 | 2003 | 989 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 81 | 0.010 |
Why?
|
| RNA | 1 | 1994 | 18 | 0.010 |
Why?
|
| DNA Primers | 1 | 1994 | 30 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 4043 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1994 | 2 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 1994 | 3 | 0.010 |
Why?
|